Fine mapping of genome-wide association study signals to identify genetic markers of the plasma triglyceride response to an omega-3 fatty acid supplementation
- 1 January 2019
- journal article
- research article
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 109 (1) , 176-185
Abstract
Using a genome-wide association study (GWAS) approach, our group previously computed a genetic risk score (GRS) from single nucleotide polymorphisms (SNPs) of 10 loci that affect the plasma triglyceride (TG) response to an omega-3 (n-3) fatty acid (FA) supplementation. The objective was to compute a novel and more refined GRS using fine mapping to include a large number of genetic variants. A total of 208 participants of the Fatty Acid Sensor (FAS) Study received 5 g fish oil/d, containing 1.9-2.2 g eicosapentaenoic acid and 1.1 g docosahexanoic acid, for 6 wk. Plasma TG concentrations were measured before and after supplementation. Dense genotyping and genotype imputation were used to refine mapping around GWAS hits. A GRS was computed by summing the number of at-risk alleles of tagging SNPs. Analyses were replicated in samples of the FINGEN study. A total of 31 tagging SNPs associated with the TG response were used for GRS calculation in the FAS study. In a general linear model adjusted for age, sex, and body mass index, the GRS explained 49.73% of TG response variance (P < 0.0001). Nonresponders to the n-3 FA supplementation had a higher GRS than did responders. In the FINGEN replication study, the GRS explained 3.67% of TG response variance (P = 0.0006). Fine mapping proved to be effective to refine the previous GRS. Carrying increasing numbers of at-risk alleles of 31 SNPs confers a higher risk of being nonresponsive to n-3 FAs. The genetic profile therefore appears to be an important determinant of the plasma TG response to an n-3 FA supplementation and could be used to target those most likely to gain clinical benefit. This trial was registered at http://www.clinicaltrials.gov as NCT01343342.Keywords
Funding Information
- Réseau de recherche en santé cardiométabolique, diabète et obésité
- Canadian Institutes of Health Research (MOP-110975)
- UK Food Standards Agency (RRD7/N02/A)
This publication has 29 references indexed in Scilit:
- Differences in metabolomic and transcriptomic profiles between responders and non-responders to an n-3 polyunsaturated fatty acids (PUFAs) supplementationGenes & Nutrition, 2012
- Novel Genetic Loci Identified for the Pathophysiology of Childhood Obesity in the Hispanic PopulationPLOS ONE, 2012
- Association between Polymorphisms in the Fatty Acid Desaturase Gene Cluster and the Plasma Triacylglycerol Response to an n-3 PUFA SupplementationNutrients, 2012
- The Role of Triglycerides in AtherosclerosisCurrent Cardiology Reports, 2011
- The Impact of Common Gene Variants on the Response of Biomarkers of Cardiovascular Disease (CVD) Risk to Increased Fish Oil Fatty Acids IntakesAnnual Review of Nutrition, 2011
- Regulation by Ca2+-Signaling Pathways of Adenylyl CyclasesCold Spring Harbor Perspectives in Biology, 2010
- A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association StudiesPLOS Genetics, 2009
- PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage AnalysesThe American Journal of Human Genetics, 2007
- Regulation of Lipolysis in AdipocytesAnnual Review of Nutrition, 2007
- IQCJ–SCHIP1, a novel fusion transcript encoding a calmodulin-binding IQ motif proteinBiochemical and Biophysical Research Communications, 2006